AbbVievsSS Innovations International

ABBV and SSII stock compared: price, dividend, valuation and results, from SEC filings.

SSII

SS Innovations International Inc.

$1.35

Value $270M

-18.67%
SSII's page

AbbVie (ABBV) has a market value of $521B and SS Innovations International (SSII) $270M. Over the last year, with dividends, ABBV moved +30.6% and SSII -78.3%. Dividend yield: ABBV 2.35%, SSII none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$521B

    SSII$270M

    ABBV is 1,927 times SSII

  • Revenue, 12 months

    ABBV$66.0B

    SSII$52M

    ABBV is 1,260 times SSII

  • Net income, 12 months

    ABBV$10.3B

    SSII-$12M

  • Operating margin

    ABBV32.2%

    SSII-15.8%

    48.0 points apart

  • ROIC

    ABBV25.7%

    SSII-14.3%

    40.0 points apart

  • P/E

    ABBV50.6

    SSII–

  • Dividend yield

    ABBV2.4%

    SSII0.0%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+30.5%

SSII-78.3%

50100DecFebAprJunAugOct
Returns by period
PeriodABBVWith dividendsSSIIWith dividends
1 year since November 14, 2025+30.6%Price +26.8%-78.3%Price -78.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieSSIISS Innovations International

Valuation

ABBVSSII
Valuation
Price$294.55$1.35
Market value$521B$270M
Enterprise value (EV)$591B–
P/E50.6–
P/E, 5-year median57.0–
P/B–5.1
EV/EBIT27.8–
Free cash flow yield3.6%–

Results and growth

ABBVSSII
Results and growth
Revenue, 12 months$66.0B$52M
Net income, 12 months$10.3B-$12M
Free cash flow, 12 months$18.9B-$18M
Earnings per share, 12 months$5.81-$0.06
Revenue growth, year on year8.6%105.7%
Revenue growth a year, past+5.9%over 5 years-69.1%over 3 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVSSII
Margins and returns on capital
Gross margin73.7%47.7%
Operating margin32.2%-15.8%
Net margin15.7%-23.7%
ROIC25.7%-14.3%
ROE–-27.3%

Balance sheet

ABBVSSII
Balance sheet
Cash$10.8B$14M
Total debt$80.9B–
Net debt / EBITDA3.2–
Interest cover7.1×-28.7×

Dividends and buybacks

ABBVSSII
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or SSII

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or SS Innovations International?

By market value, AbbVie ($521B) is about 1,926.7 times SS Innovations International ($270M), at today's prices.

How did ABBV and SSII stock do over the last 1 years?

Since November 14, 2025, ABBV's price moved +26.8% and SSII's -78.3%. With dividends: ABBV +30.6% (+30.6% a year), SSII -78.3% (-78.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or SSII?

The dividend yield at today's price is 2.35% for AbbVie and none for SS Innovations International. Over the last twelve months they paid $6.92 and – per share.

Which has the higher profit margins, AbbVie or SS Innovations International?

Over the last twelve months, the net margin was 15.7% for AbbVie and -23.7% for SS Innovations International, and the operating margin 32.2% and -15.8%. Revenue was $66.0B and $52M.

Which is the better investment, AbbVie or SS Innovations International?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.